Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
13.47
-0.29 (-2.11%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Jade Biosciences Market Cap
Jade Biosciences has a market cap or net worth of $856.66 million as of October 16, 2026. It is the 10,912th most valuable company in the world and the 2,318th biggest in the United States. Its market cap has increased by 165.22% in one year.
Market Cap
856.66M
Enterprise Value
396.84M
1-Year Change
165.22%
Global Rank
Country Rank
#2,318 United States
Category
ChartMarket Cap Chart
Since April 29, 2025, Jade Biosciences's market cap has increased from $326.87M to $856.66M, an increase of 162.08%. That is a compound annual growth rate of 92.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 856.66M | 20.68% |
| Dec 31, 2025 | 709.84M | 117.16% |
| Apr 29, 2025 | 326.87M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 891.28M |
| SL Science Holding | 872.51M |
| Alto Neuroscience | 860.97M |
| Rigel Pharmaceuticals | 858.71M |
| Aktis Oncology | 837.63M |
| Arbutus Biopharma | 834.92M |
| Cullinan Therapeutics | 832.11M |
| Monte Rosa Therapeutics | 830.95M |